240 related articles for article (PubMed ID: 20174843)
1. MAGE-A antigens in lesions of the oral mucosa.
Krauss E; Rauthe S; Gattenlöhner S; Reuther T; Kochel M; Kriegebaum U; Kübler AC; Müller-Richter UD
Clin Oral Investig; 2011 Jun; 15(3):315-20. PubMed ID: 20174843
[TBL] [Abstract][Full Text] [Related]
2. Premalignant and malignant oral lesions are associated with changes in the glycosylation pattern of carbohydrates related to ABH blood group antigens.
Dabelsteen E; Clausen H; Holmstrup P; Reibel J
APMIS; 1988 Sep; 96(9):813-9. PubMed ID: 3048339
[TBL] [Abstract][Full Text] [Related]
3. [Study of testicular cancer gene expression in samples of oral leukoplakia and squamous cell carcinoma of the mouth].
Skorodumova LO; Muraev AA; Zakharova ES; Shepelev MV; Korobko IV; Zaderenko IA; Ivanov SIu; Gnuchev NV; Georgiev GP; Larin SS
Vopr Onkol; 2012; 58(4):486-92. PubMed ID: 23607202
[TBL] [Abstract][Full Text] [Related]
4. Langerhans cells in epithelial tumors and benign lesions of the oropharynx.
Girod SC; Kühnast T; Ulrich S; Krueger GR
In Vivo; 1994; 8(4):543-7. PubMed ID: 7893981
[TBL] [Abstract][Full Text] [Related]
5. [Precancerous lesions of the buccal mucosa].
Ben Slama L
Rev Stomatol Chir Maxillofac; 2001 Apr; 102(2):77-108. PubMed ID: 11446145
[TBL] [Abstract][Full Text] [Related]
6. Expression of the CA1 determinant by carcinomas and by non-malignant epithelial cells in oral lesions.
Shabana AH; Ivanyi L; Kramer IR
Br J Cancer; 1983 Oct; 48(4):527-31. PubMed ID: 6354238
[TBL] [Abstract][Full Text] [Related]
7. Reactivity of monoclonal antibodies 17.13 and 63.12 with oral epithelial dysplasia and hyperkeratosis.
Merrell P; Carpenter W; Silverman S; Leider A; Gallo J
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Mar; 83(3):367-72. PubMed ID: 9084201
[TBL] [Abstract][Full Text] [Related]
8. Potentially Malignant Oral Disorders and Cancer Transformation.
Ganesh D; Sreenivasan P; Öhman J; Wallström M; Braz-Silva PH; Giglio D; Kjeller G; Hasséus B
Anticancer Res; 2018 Jun; 38(6):3223-3229. PubMed ID: 29848669
[TBL] [Abstract][Full Text] [Related]
9. [Determination of human papillomavirus in oral leukoplakia,oral lichen planus and oral squamous cell carcinoma].
Cao J; Jin JQ; Deng DJ; Liu HW
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):84-8. PubMed ID: 26885914
[TBL] [Abstract][Full Text] [Related]
10. Expression of mucin type carbohydrates may supplement histologic diagnosis in oral premalignant lesions.
Bryne M; Reibel J; Mandel U; Dabelsteen E
J Oral Pathol Med; 1991 Mar; 20(3):120-5. PubMed ID: 1709970
[TBL] [Abstract][Full Text] [Related]
11. The expression of cell surface MHC class I heavy and light chain molecules in pre-malignant and malignant lesions of the oral mucosa.
Prime SS; Pitigala-Arachchi A; Crane IJ; Rosser TJ; Scully C
Histopathology; 1987 Jan; 11(1):81-91. PubMed ID: 3549515
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of MAGE-A expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
Ries J; Agaimy A; Vairaktaris E; Kwon Y; Neukam FW; Strassburg LH; Nkenke E
Int J Oncol; 2012 Sep; 41(3):1085-93. PubMed ID: 22751922
[TBL] [Abstract][Full Text] [Related]
13. MAGE-A expression in oral and laryngeal leukoplakia predicts malignant transformation.
Baran CA; Agaimy A; Wehrhan F; Weber M; Hille V; Brunner K; Wickenhauser C; Siebolts U; Nkenke E; Kesting M; Ries J
Mod Pathol; 2019 Jul; 32(8):1068-1081. PubMed ID: 30936424
[TBL] [Abstract][Full Text] [Related]
14. Epithelial isoantigens A, B and H in oral carcinomas.
Gupta YN; Gupta S; Singh IJ; Khanna NN; Agarwal MK
Ear Nose Throat J; 1985 May; 64(5):239-42. PubMed ID: 3996275
[No Abstract] [Full Text] [Related]
15. Langerhans cells and T cells sense cell dysplasia in oral leukoplakias and oral squamous cell carcinomas--evidence for immunosurveillance.
Öhman J; Magnusson B; Telemo E; Jontell M; Hasséus B
Scand J Immunol; 2012 Jul; 76(1):39-48. PubMed ID: 22469080
[TBL] [Abstract][Full Text] [Related]
16. Oral brush biopsy and melanoma-associated antigens A (MAGE-A) staining in clinically suspicious lesions.
Hartmann S; Kipke RU; Rauthe S; Mutzbauer G; Brands RC; Ebhardt H; Kübler AC; Müller-Richter UD
J Craniomaxillofac Surg; 2015 Dec; 43(10):2214-8. PubMed ID: 26589180
[TBL] [Abstract][Full Text] [Related]
17. Reliability of toluidine blue application in the detection of oral epithelial dysplasia and in situ and invasive squamous cell carcinomas.
Onofre MA; Sposto MR; Navarro CM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 May; 91(5):535-40. PubMed ID: 11346731
[TBL] [Abstract][Full Text] [Related]
18. Proliferating cell nuclear antigen (PCNA) as a marker of dysplasia in oral mucosa.
Martínez-Lara I; González-Moles MA; Ruiz-Avila I; Bravo M; Ramos MC; Fernández-Martínez JA
Acta Stomatol Belg; 1996 Mar; 93(1):29-32. PubMed ID: 8986050
[TBL] [Abstract][Full Text] [Related]
19. p53 and Ki 67 expression in preneoplastic and neoplastic lesions of the oral mucosa.
Girod SC; Krueger G; Pape HD
Int J Oral Maxillofac Surg; 1993 Oct; 22(5):285-8. PubMed ID: 8245568
[TBL] [Abstract][Full Text] [Related]
20. Prospective, blinded comparison of cytology and DNA-image cytometry of brush biopsies for early detection of oral malignancy.
Kämmerer PW; Koch FP; Santoro M; Babaryka G; Biesterfeld S; Brieger J; Kunkel M
Oral Oncol; 2013 May; 49(5):420-6. PubMed ID: 23318121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
